Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2335 studies found for:    hormone therapy AND (woman OR women OR female)
Show Display Options
Rank Status Study
21 Terminated Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Acupuncture;   Procedure: Sham acupuncture therapy;   Procedure: Observation
22 Terminated High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Condition: Breast Cancer
Intervention: Biological: esterified estrogens
23 Unknown  Paclitaxel, Cyclophosphamide, and Doxorubicin Followed by Autologous Dendritic Cells and Surgery With or Without Radiation Therapy and/or Hormone Therapy in Treating Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: therapeutic autologous dendritic cells;   Drug: aromatase inhibition therapy;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: biopsy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
24 Active, not recruiting Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Letrozole
25 Active, not recruiting Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors
Conditions: Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Intervention: Drug: Exemestane
26 Completed Views and Attitudes of Oncologists and Geriatricians on the Use of Chemotherapy and Hormone Therapy in Treating Older and/or Frail Women With Breast Cancer
Condition: Breast Cancer
Intervention: Other: survey administration
27 Completed Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
Conditions: Atherosclerosis;   Chlamydia Infections;   Cytomegalovirus Infections;   Pneumonia, Bacterial;   Postmenopause
Intervention: Drug: Estrogen therapy
28 Withdrawn Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
Conditions: Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: exemestane;   Procedure: adjuvant therapy;   Procedure: aromatase inhibition;   Procedure: conventional surgery;   Procedure: endocrine therapy;   Procedure: hormone therapy;   Procedure: neoadjuvant therapy;   Procedure: surgery
29 Completed Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
Conditions: Postmenopausal Vasomotor Symptoms;   Cardiovascular Disease
Interventions: Drug: 17-b-estradiol;   Drug: 17-b-estradiol + medroxyprogeterone acetate;   Drug: 17-b-estradiol hemihydrate;   Drug: placebo pill + gel
30 Completed Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
Conditions: Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: lapatinib ditosylate;   Drug: fulvestrant;   Other: placebo;   Other: laboratory biomarker analysis
31 Completed
Has Results
Early Menopause Hormone Treatment and Cognition
Condition: Menopausal Syndrome
Interventions: Drug: Estradiol (E2);   Drug: Progesterone (P10) x90;   Drug: Progesterone (P10) x10
32 Withdrawn Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer
Conditions: Stage IV Breast Cancer;   Recurrent Breast Cancer
Interventions: Drug: tamoxifen;   Drug: trastuzumab;   Procedure: antibody therapy;   Procedure: antiestrogen therapy;   Procedure: biological response modifier therapy;   Procedure: drug resistance inhibition;   Procedure: endocrine therapy;   Procedure: hormone therapy;   Procedure: monoclonal antibody therapy
33 Completed The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer
Conditions: Neoadjuvant Therapy;   Chemotherapy;   Hormone Replacement Therapy;   Breast Cancer
Intervention:
34 Completed LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer
Condition: Local Advanced or Metastatic Postmenopausal Breast Cancer
Intervention:
35 Completed Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
Condition: Endometrial Cancer
Interventions: Drug: medroxyprogesterone;   Drug: ethinyl estradiol;   Drug: norgestrel;   Other: laboratory biomarker analysis
36 Recruiting Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
Condition: Female Breast Cancer
Intervention: Drug: Toremifene; Anastrozole
37 Not yet recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
38 Completed Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: tamoxifen citrate;   Drug: toremifene
39 Unknown  Comparison of Hormonal Therapy: Mediating Hot Flashes Tapering Regimens for Mediating Hot Flashes
Conditions: Hot Flashes;   Night Sweats
Intervention: Drug: Estradiol
40 Active, not recruiting Examining the Relationship Between Hormone Therapy and Cognitive Function (The WHIMS-ECHO Study)
Condition: Dementia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years